Revenue: As of FY2025 Q3, the actual value is USD 23.49 M.EPS: As of FY2025 Q3, the actual value is USD 0.09.EBIT: As of FY2025 Q3, the actual value is USD 2.88 M.<h3>Segment Revenue</h3><ul><li>Legacy FitLife: Revenue for the three months ended September 30, 2025 was $12,855, a 5% decrease compared to the previous year.</li><li>MusclePharm: Revenue for the three months ended September 30, 2025 was $3,809, a 55% increase compared to the same quarter last year.</li><li>Irwin: Revenue for the three months ended September 30, 2025 was $6,821.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: For the three months ended September 30, 2025, net income was $921, compared to $2,126 for the same period in 2024.</li><li>Gross Margin: Gross margin for the three months ended September 30, 2025 decreased to 37.2% from 43.8% for the comparable prior period.</li><li>Operating Income: Operating income for the three months ended September 30, 2025 was $2,318, compared to $3,182 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Cash provided by operating activities for the nine months ended September 30, 2025 was $7,195, compared to $8,653 for the nine months ended September 30, 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Contribution Margin: For Legacy FitLife, contribution as a percentage of revenue decreased to 36.2% from 37.9% over the same time period.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The Company anticipates that increased promotional efforts for MusclePharm will continue for the foreseeable future, which may cause fluctuations in gross margin and contribution margin as a percent of revenue.</li><li>Non-Core Business: The acquisition of Irwin Naturals is expected to augment and diversify the Company’s product offerings and lineup, with the opportunity to generate future synergies within the nutritional supplement and wellness business.</li></ul>

FitLife Brands | 10-Q: FY2025 Q3 Revenue: USD 23.49 M